194 related articles for article (PubMed ID: 27822121)
1. The Danish nationwide clinical register for patients with rheumatoid arthritis: DANBIO.
Ibfelt EH; Jensen DV; Hetland ML
Clin Epidemiol; 2016; 8():737-742. PubMed ID: 27822121
[TBL] [Abstract][Full Text] [Related]
2. Validity and completeness of rheumatoid arthritis diagnoses in the nationwide DANBIO clinical register and the Danish National Patient Registry.
Ibfelt EH; Sørensen J; Jensen DV; Dreyer L; Schiøttz-Christensen B; Thygesen PH; Colic A; Raun JL; Manilo N; Rødgaard A; Poulsen UE; Rasmussen C; Hansen T; Unger B; Pelck R; Kincses A; Nordin H; Lorenzen T; Theibich A; Jensen Hansen IM; Espesen J; Grydehøj J; Holland-Fischer M; Loft AG; Hetland ML
Clin Epidemiol; 2017; 9():627-632. PubMed ID: 29238225
[TBL] [Abstract][Full Text] [Related]
3. Discordance of Global Assessments by Patient and Physician Is Higher in Female than in Male Patients Regardless of the Physician's Sex: Data on Patients with Rheumatoid Arthritis, Axial Spondyloarthritis, and Psoriatic Arthritis from the DANBIO Registry.
Lindström Egholm C; Krogh NS; Pincus T; Dreyer L; Ellingsen T; Glintborg B; Kowalski MR; Lorenzen T; Madsen OR; Nordin H; Rasmussen C; Hetland ML
J Rheumatol; 2015 Oct; 42(10):1781-5. PubMed ID: 26233511
[TBL] [Abstract][Full Text] [Related]
4. Enthesitis in patients with psoriatic arthritis and axial spondyloarthritis - data from the Danish nationwide DANBIO registry.
Mathew AJ; Glintborg B; Krogh NS; Hetland ML; Østergaard M
Semin Arthritis Rheum; 2022 Feb; 52():151948. PubMed ID: 35027245
[TBL] [Abstract][Full Text] [Related]
5. Self-protection strategies and health behaviour in patients with inflammatory rheumatic diseases during the COVID-19 pandemic: results and predictors in more than 12 000 patients with inflammatory rheumatic diseases followed in the Danish DANBIO registry.
Glintborg B; Jensen DV; Engel S; Terslev L; Pfeiffer Jensen M; Hendricks O; Ostergaard M; Horskjær Rasmussen S; Adelsten T; Colic A; Danebod K; Kildemand M; Loft AG; Munk HL; Pedersen JK; Østgård RD; Møller Sørensen C; Krogh NS; Agerbo J; Ziegler C; Hetland M
RMD Open; 2021 Jan; 7(1):. PubMed ID: 33402443
[TBL] [Abstract][Full Text] [Related]
6. Pain and pain mechanisms in patients with inflammatory arthritis: A Danish nationwide cross-sectional DANBIO registry survey.
Rifbjerg-Madsen S; Christensen AW; Christensen R; Hetland ML; Bliddal H; Kristensen LE; Danneskiold-Samsøe B; Amris K
PLoS One; 2017; 12(7):e0180014. PubMed ID: 28686639
[TBL] [Abstract][Full Text] [Related]
7. Monitoring patients with rheumatoid arthritis in routine care: experiences from a treat-to-target strategy using the DANBIO registry.
Hetland ML; Jensen DV; Krogh NS
Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-141-6. PubMed ID: 25365104
[TBL] [Abstract][Full Text] [Related]
8. A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis: 1-year clinical outcomes from the DANBIO registry.
Glintborg B; Sørensen IJ; Loft AG; Lindegaard H; Linauskas A; Hendricks O; Hansen IMJ; Jensen DV; Manilo N; Espesen J; Klarlund M; Grydehøj J; Dieperink SS; Kristensen S; Olsen JS; Nordin H; Chrysidis S; Dalsgaard Pedersen D; Sørensen MV; Andersen LS; Grøn KL; Krogh NS; Pedersen L; Hetland ML;
Ann Rheum Dis; 2017 Aug; 76(8):1426-1431. PubMed ID: 28473425
[TBL] [Abstract][Full Text] [Related]
9. Comparing patient-reported outcomes entered at home versus at hospital, and testing touch screens for initial recruitment to scientific trials in arthritis patients.
Secher AE; Glintborg B; Gudbergsen H; Krogh NS; Sørensen IJ; Jensen DV; Christensen R; Skougaard M; Pedersen PL; Hetland ML
Scand J Rheumatol; 2019 May; 48(3):178-184. PubMed ID: 30444168
[TBL] [Abstract][Full Text] [Related]
10. Which factors influence radiographic progression during treatment with tumor necrosis factor inhibitors in clinical practice? Results from 930 patients with rheumatoid arthritis in the nationwide Danish DANBIO registry.
Ørnbjerg LM; Østergaard M; Bøyesen P; Krogh NS; Thormann A; Tarp U; Poulsen UE; Espesen J; Schlemmer A; Graudal N; Kollerup G; Jensen DV; Madsen OR; Glintborg B; Christensen T; Lindegaard H; Bøhme W; Hansen A; Andersen AR; Hetland ML
J Rheumatol; 2014 Dec; 41(12):2352-60. PubMed ID: 25274894
[TBL] [Abstract][Full Text] [Related]
11. DANBIO: a nationwide registry of biological therapies in Denmark.
Hetland ML
Clin Exp Rheumatol; 2005; 23(5 Suppl 39):S205-7. PubMed ID: 16273809
[TBL] [Abstract][Full Text] [Related]
12. Predictors of revision, prosthetic joint infection and mortality following total hip or total knee arthroplasty in patients with rheumatoid arthritis: a nationwide cohort study using Danish healthcare registers.
Cordtz RL; Zobbe K; Højgaard P; Kristensen LE; Overgaard S; Odgaard A; Lindegaard H; Dreyer L
Ann Rheum Dis; 2018 Feb; 77(2):281-288. PubMed ID: 29097373
[TBL] [Abstract][Full Text] [Related]
13. To switch or not to switch: results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registry.
Glintborg B; Loft AG; Omerovic E; Hendricks O; Linauskas A; Espesen J; Danebod K; Jensen DV; Nordin H; Dalgaard EB; Chrysidis S; Kristensen S; Raun JL; Lindegaard H; Manilo N; Jakobsen SH; Hansen IMJ; Dalsgaard Pedersen D; Sørensen IJ; Andersen LS; Grydehøj J; Mehnert F; Krogh NS; Hetland ML
Ann Rheum Dis; 2019 Feb; 78(2):192-200. PubMed ID: 30396903
[TBL] [Abstract][Full Text] [Related]
14. A real-life analysis of patients with rheumatologic diseases on biological treatments: Data from TURKBIO Registry.
Önen F; Can G; Çapar S; Dalkılıç E; Pehlivan Y; Şenel S; Akar S; Koca SS; Tufan A; Yazıcı A; Yılmaz S; İnanç N; Sarı İ; Birlik M; Solmaz D; Cefle A; Öztürk MA; Yolbaş S; Krogh NS; Yılmaz N; Erten Ş; Bes C; Gündüz ÖS; Göker B; Haznedaroğlu S; Yavuz Ş; Yildirim Çetin G; Yıldız F; Direskeneli H; Akkoç N
Eur J Rheumatol; 2022 Apr; 9(2):82-87. PubMed ID: 35546332
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for
Dieperink SS; Glintborg B; Oestergaard LB; Nørgaard M; Benfield T; Mehnert F; Petersen A; Hetland ML
BMJ Open; 2019 Sep; 9(9):e030999. PubMed ID: 31481566
[TBL] [Abstract][Full Text] [Related]
16. DANBIO--powerful research database and electronic patient record.
Hetland ML
Rheumatology (Oxford); 2011 Jan; 50(1):69-77. PubMed ID: 21148154
[TBL] [Abstract][Full Text] [Related]
17. Does a mandatory non-medical switch from originator to biosimilar etanercept lead to increase in healthcare use and costs? A Danish register-based study of patients with inflammatory arthritis.
Glintborg B; Ibsen R; Bilbo REQ; Lund Hetland M; Kjellberg J
RMD Open; 2019; 5(2):e001016. PubMed ID: 31452931
[TBL] [Abstract][Full Text] [Related]
18. Structural joint damage and hand bone loss in patients with rheumatoid arthritis.
Ørnbjerg LM
Dan Med J; 2018 Mar; 65(3):. PubMed ID: 29510810
[TBL] [Abstract][Full Text] [Related]
19. Comparative Effectiveness of Certolizumab Pegol, Abatacept, and Biosimilar Infliximab in Patients With Rheumatoid Arthritis Treated in Routine Care: Observational Data From the Danish DANBIO Registry Emulating a Randomized Trial.
Grøn KL; Glintborg B; Nørgaard M; Mehnert F; Østergaard M; Dreyer L; Krogh NS; Bjørner JB; Hetland ML
Arthritis Rheumatol; 2019 Dec; 71(12):1997-2004. PubMed ID: 31268624
[TBL] [Abstract][Full Text] [Related]
20. Modern treatment strategies in rheumatoid arthritis.
Hetland ML
Dan Med Bull; 2011 Nov; 58(11):B4320. PubMed ID: 22047935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
